Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Thescientificworldjournal|August 15, 2006
Treating imatinib-resistant leukemia: the next generation targeted therapiesMichael R Burgess, Charles L Sawyers
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceMichael R Burgess, Brian J Skaggs, Neil P Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2014
MAGI-2 scaffold protein is critical for kidney barrier functionMinna D Balbas, Michael R Burgess, Rajmohan Murali, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional RemodelingBenjamin J Huang, Jeevitha D'Souza, Alexa Rane Batingana, et al.
Blood|November 2, 2014
Preclinical efficacy of MEK inhibition in Nras-mutant AMLMichael R Burgess, Eugene Hwang, Ari J Firestone, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutantsBrian J Skaggs, Mercedes E Gorre, Ann Ryvkin, et al.
Science Signaling|December 5, 2013
PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic KrasErnesto Diaz-Flores, Hana Goldschmidt, Philippe Depeille, et al.
Elife|July 21, 2015
Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesisJasmine C Wong, Kelley M Weinfurtner, Maria Del Pilar Alzamora, et al.
Pageof 2